1921
Volume 68, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Anecdotal historical evidence suggests that tuberculosis was uncommon at high altitude, but whether transmission is affected by high altitude is not known. To test whether high altitude lowers infection by , the prevalence of tuberculin skin test (TST) positivity was compared between two high altitude villages (3,340 meters [10,960 feet] and 3,500 meters [11,480 feet]) and three sea-level sites in Peru. High altitude villages had lower TST-positive prevalence rates (5.7% and 6.8%) than sea level areas (25–33%), and the difference remained significant (odds ratio = 4.5–6.0) after adjusting for age, education, bacille Calmette-Guérin vaccination, and contact with tuberculosis patients. The TST-positive individuals clustered within highland families more than within sea level families. These data suggest that prevention and control efforts targeted to families may be more effective at high altitude. The mechanism by which TST-positivity prevalence is decreased at high altitude is unknown, but may reflect relative hypoxia, low humidity, or an increased ultraviolet effect.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2003.68.721
2003-06-01
2017-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/68/6/0680721.html?itemId=/content/journals/10.4269/ajtmh.2003.68.721&mimeType=html&fmt=ahah

References

  1. World Health Organization, 2001. WHO Report 2001: Global TB Control. Geneva: World Health Organization.
  2. World Health Organization, 2000. Peru: Epidemiological Fact Sheet on HIV/AIDS and Sexually Transmitted Infections: 2000 Update. Geneva: World Health Organization.
  3. Rogers FB, 1969. The rise and decline of the altitude therapy of tuberculosis. Bull Hist Med 43 : 1–16.
  4. Smith A, 1840. Practical observations on the diseases of Peru, described as they occur on the coast and in the sierra. Edinburgh Med Surg J 54 : 1–19.
  5. Thomas Mann, 1924. Magic Mountain. New York: Knopf.
  6. Fourie PB, 1983. The prevalence and annual rate of tuberculous infection in South Africa. Tubercle 64 : 181–192.
  7. Mansoer JR, Kibuga DK, Borgdorff MW, 1999. Altitude: a determinant for tuberculosis in Kenya? Int J Tuberc Lung Dis 3 : 156–161.
  8. Rich AR, Follis RH, 1942. The effect of low oxygen tension upon the development of experimental tuberculosis. Bull Johns Hopkins Hosp 71 : 193–202, 345–363.
  9. Bates LR, Busk T, Palmer CE, 1951. Tuberculin Sensitivity at Different Altitudes of Residence. Copenhagen, Denmark: World Health Organization. Tuberculosis Research Office. Research Contributions of BCG Vaccination Programs.
  10. Getchell WS, Davis CE, Gilman J, Urueta G, Ruiz-Huidobro E, Gilman RH, 1992. Basic epidemiology of tuberculosis in Peru: a prevalence study of tuberculin sensitivity in a Pueblo Joven. Am J Trop Med Hyg 47 : 721–729.
  11. Jordan TL, Sunderam G, Thomas L, Reichman LB, 1987. Tuberculin reaction size measurement by the pen method compared to traditional palpation. Chest 92 : 234–236.
  12. American Thoracic Society and the Center for Disease Control and Prevention, 2000. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 161 : 1376–1395.
  13. Ministry of Health, 2000. Dirección del programa nacional de control de enfermedades transmisibles control de la tuberculosis. Actualizacion en la Tecnica de Aplicación, Lectura e Interpretación de la Prueba de Tuberculina. Directiva No. 003 –2000 -PCT. Lima, Peru: Ministry of Health.
  14. Conway MR, 1990. A random effects model for binary data. Biometrics 46 : 317–328.
  15. Hauck WW, Donner A, 1977. Wald’s test as applied to hypotheses in logit analysis. J Am Stat Assoc 72 : 851–853.
  16. Gould W, Sribney W, 1999. Maximum Likelihood Estimation with STATA. College Station, TX: Stata Press.
  17. Moro PL, Checkley W, Gilman RH, Cabrera L, Lescano AG, Bonilla JJ, Silva B, 2000. Gallstone disease in Peruvian costal natives and highland migrants. Gut 46 : 569–573.
  18. Madico G, Gilman RH, Checkley W, Cabrera L, Kohlstadt I, Kacena K, Diaz JF, Black R, 1995. Community infection ratio as an indicator for tuberculosis control. Lancet 345 : 416–419.
  19. Sever JL, Youmans GP, 1957. The relation of oxygen tension to virulence of tuberculosis bacilli and to acquired resistance in tuberculosis. J Infect Dis 101 : 1427–1442.
  20. Riley RL, Knight M, Middlebrook G, 1976. Ultraviolet susceptibility of BCG and virulent tubercle bacilli. Am Rev Respir Dis 113 : 413–418.
  21. Menzies D, Fanning A, Yuan L, Fitzgerald M, 1995. Tuberculosis among health care workers. N Engl J Med 332 : 92–98.
  22. Ko G, First MW, Burge HA, 2000. Influence of relative humidity on particle size and UV sensitivity of Serratia marcescens and Mycobacterium bovis BCG aerosols. Tuber Lung Dis 80 : 217–228.
  23. Riley RL, Kaufman JE, 1972. Effect of relative humidity on the inactivation of airborne Serratia marcescens by ultraviolet radiation. Appl Microbiol 23 : 1113–1120.
  24. Comstock GW, Ferebee SH, Hammes LM, 1967. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 95 : 935–943.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2003.68.721
Loading
/content/journals/10.4269/ajtmh.2003.68.721
Loading

Data & Media loading...

  • Received : 01 Oct 2002
  • Accepted : 03 Mar 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error